Wyeth wins OK to sell Pristiq for depression
NEW YORK (Reuters) - Drugmaker Wyeth won U.S. approval to sell a drug called Pristiq to treat depression, the U.S. Food and Drug Administration said on Friday.
<p>You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~a/reuters/healthNews?i=euSk2y" border="0)
</img>
</p><div class="feedflare">
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=9kBgz3E" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=XVgJ66e" border="0)
</img>
You are not allowed to view links.
Register or
Login![](http://feeds.reuters.com/~f/reuters/healthNews?i=EVKjISe" border="0)
</img>
</div>
![](http://feeds.reuters.com/~r/reuters/healthNews/~4/243599279" height="1" width="1)
You are not allowed to view links.
Register or
Login
